Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice
The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation.
Autor*in: |
Jabara, Haifa H. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
Transmembrane activator and calcium modulator ligand interactor |
---|
Umfang: |
11722 |
---|
Übergeordnetes Werk: |
Enthalten in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward - Papakitsou, I. ELSEVIER, 2022, official publication of the American Academy of Allergy, Asthma and Immunology, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:139 ; year:2017 ; number:4 ; pages:1293-13014 ; extent:11722 |
Links: |
---|
DOI / URN: |
10.1016/j.jaci.2016.07.028 |
---|
Katalog-ID: |
ELV01471776X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV01471776X | ||
003 | DE-627 | ||
005 | 20230623115317.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaci.2016.07.028 |2 doi | |
028 | 5 | 2 | |a GBVA2017001000003.pica |
035 | |a (DE-627)ELV01471776X | ||
035 | |a (ELSEVIER)S0091-6749(16)30892-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.85 |2 bkl | ||
100 | 1 | |a Jabara, Haifa H. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
264 | 1 | |c 2017 | |
300 | |a 11722 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. | ||
650 | 7 | |a pneumococcal susceptibility |2 Elsevier | |
650 | 7 | |a B cells |2 Elsevier | |
650 | 7 | |a Transmembrane activator and calcium modulator ligand interactor |2 Elsevier | |
650 | 7 | |a common variable immunodeficiency |2 Elsevier | |
650 | 7 | |a natural antibodies |2 Elsevier | |
700 | 1 | |a Lee, John J. |4 oth | |
700 | 1 | |a Janssen, Erin |4 oth | |
700 | 1 | |a Ullas, Sumana |4 oth | |
700 | 1 | |a Liadaki, Kyriaki |4 oth | |
700 | 1 | |a Garibyan, Lilit |4 oth | |
700 | 1 | |a Benson, Halli |4 oth | |
700 | 1 | |a Sannikova, Tatyana |4 oth | |
700 | 1 | |a Bram, Richard |4 oth | |
700 | 1 | |a Hammarstrom, Lennart |4 oth | |
700 | 1 | |a Cruz, Anthony C. |4 oth | |
700 | 1 | |a Siegel, Richard |4 oth | |
700 | 1 | |a Manis, John |4 oth | |
700 | 1 | |a Malley, Richard |4 oth | |
700 | 1 | |a Geha, Raif S. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Papakitsou, I. ELSEVIER |t Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |d 2022 |d official publication of the American Academy of Allergy, Asthma and Immunology |g Amsterdam [u.a.] |w (DE-627)ELV000021164 |
773 | 1 | 8 | |g volume:139 |g year:2017 |g number:4 |g pages:1293-13014 |g extent:11722 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jaci.2016.07.028 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
951 | |a AR | ||
952 | |d 139 |j 2017 |e 4 |h 1293-13014 |g 11722 | ||
953 | |2 045F |a 610 |
author_variant |
h h j hh hhj |
---|---|
matchkey_str |
jabarahaifahleejohnjjanssenerinullassuma:2017----:eeoyoiyotasebaeciaoadacumdltriadneatr14cuehponufcec |
hierarchy_sort_str |
2017 |
bklnumber |
44.85 |
publishDate |
2017 |
allfields |
10.1016/j.jaci.2016.07.028 doi GBVA2017001000003.pica (DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Jabara, Haifa H. verfasserin aut Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice 2017 11722 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier Lee, John J. oth Janssen, Erin oth Ullas, Sumana oth Liadaki, Kyriaki oth Garibyan, Lilit oth Benson, Halli oth Sannikova, Tatyana oth Bram, Richard oth Hammarstrom, Lennart oth Cruz, Anthony C. oth Siegel, Richard oth Manis, John oth Malley, Richard oth Geha, Raif S. oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:139 year:2017 number:4 pages:1293-13014 extent:11722 https://doi.org/10.1016/j.jaci.2016.07.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 139 2017 4 1293-13014 11722 045F 610 |
spelling |
10.1016/j.jaci.2016.07.028 doi GBVA2017001000003.pica (DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Jabara, Haifa H. verfasserin aut Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice 2017 11722 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier Lee, John J. oth Janssen, Erin oth Ullas, Sumana oth Liadaki, Kyriaki oth Garibyan, Lilit oth Benson, Halli oth Sannikova, Tatyana oth Bram, Richard oth Hammarstrom, Lennart oth Cruz, Anthony C. oth Siegel, Richard oth Manis, John oth Malley, Richard oth Geha, Raif S. oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:139 year:2017 number:4 pages:1293-13014 extent:11722 https://doi.org/10.1016/j.jaci.2016.07.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 139 2017 4 1293-13014 11722 045F 610 |
allfields_unstemmed |
10.1016/j.jaci.2016.07.028 doi GBVA2017001000003.pica (DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Jabara, Haifa H. verfasserin aut Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice 2017 11722 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier Lee, John J. oth Janssen, Erin oth Ullas, Sumana oth Liadaki, Kyriaki oth Garibyan, Lilit oth Benson, Halli oth Sannikova, Tatyana oth Bram, Richard oth Hammarstrom, Lennart oth Cruz, Anthony C. oth Siegel, Richard oth Manis, John oth Malley, Richard oth Geha, Raif S. oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:139 year:2017 number:4 pages:1293-13014 extent:11722 https://doi.org/10.1016/j.jaci.2016.07.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 139 2017 4 1293-13014 11722 045F 610 |
allfieldsGer |
10.1016/j.jaci.2016.07.028 doi GBVA2017001000003.pica (DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Jabara, Haifa H. verfasserin aut Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice 2017 11722 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier Lee, John J. oth Janssen, Erin oth Ullas, Sumana oth Liadaki, Kyriaki oth Garibyan, Lilit oth Benson, Halli oth Sannikova, Tatyana oth Bram, Richard oth Hammarstrom, Lennart oth Cruz, Anthony C. oth Siegel, Richard oth Manis, John oth Malley, Richard oth Geha, Raif S. oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:139 year:2017 number:4 pages:1293-13014 extent:11722 https://doi.org/10.1016/j.jaci.2016.07.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 139 2017 4 1293-13014 11722 045F 610 |
allfieldsSound |
10.1016/j.jaci.2016.07.028 doi GBVA2017001000003.pica (DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Jabara, Haifa H. verfasserin aut Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice 2017 11722 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier Lee, John J. oth Janssen, Erin oth Ullas, Sumana oth Liadaki, Kyriaki oth Garibyan, Lilit oth Benson, Halli oth Sannikova, Tatyana oth Bram, Richard oth Hammarstrom, Lennart oth Cruz, Anthony C. oth Siegel, Richard oth Manis, John oth Malley, Richard oth Geha, Raif S. oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:139 year:2017 number:4 pages:1293-13014 extent:11722 https://doi.org/10.1016/j.jaci.2016.07.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 139 2017 4 1293-13014 11722 045F 610 |
language |
English |
source |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:139 year:2017 number:4 pages:1293-13014 extent:11722 |
sourceStr |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:139 year:2017 number:4 pages:1293-13014 extent:11722 |
format_phy_str_mv |
Article |
bklname |
Kardiologie Angiologie |
institution |
findex.gbv.de |
topic_facet |
pneumococcal susceptibility B cells Transmembrane activator and calcium modulator ligand interactor common variable immunodeficiency natural antibodies |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
authorswithroles_txt_mv |
Jabara, Haifa H. @@aut@@ Lee, John J. @@oth@@ Janssen, Erin @@oth@@ Ullas, Sumana @@oth@@ Liadaki, Kyriaki @@oth@@ Garibyan, Lilit @@oth@@ Benson, Halli @@oth@@ Sannikova, Tatyana @@oth@@ Bram, Richard @@oth@@ Hammarstrom, Lennart @@oth@@ Cruz, Anthony C. @@oth@@ Siegel, Richard @@oth@@ Manis, John @@oth@@ Malley, Richard @@oth@@ Geha, Raif S. @@oth@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV000021164 |
dewey-sort |
3610 |
id |
ELV01471776X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01471776X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623115317.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2016.07.028</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017001000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01471776X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(16)30892-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jabara, Haifa H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11722</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pneumococcal susceptibility</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transmembrane activator and calcium modulator ligand interactor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">common variable immunodeficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">natural antibodies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, John J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Janssen, Erin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ullas, Sumana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liadaki, Kyriaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garibyan, Lilit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benson, Halli</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sannikova, Tatyana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bram, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hammarstrom, Lennart</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cruz, Anthony C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Siegel, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manis, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malley, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geha, Raif S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:139</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:1293-13014</subfield><subfield code="g">extent:11722</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2016.07.028</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">139</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">1293-13014</subfield><subfield code="g">11722</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Jabara, Haifa H. |
spellingShingle |
Jabara, Haifa H. ddc 610 bkl 44.85 Elsevier pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
authorStr |
Jabara, Haifa H. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000021164 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.85 bkl Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies Elsevier |
topic |
ddc 610 bkl 44.85 Elsevier pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies |
topic_unstemmed |
ddc 610 bkl 44.85 Elsevier pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies |
topic_browse |
ddc 610 bkl 44.85 Elsevier pneumococcal susceptibility Elsevier B cells Elsevier Transmembrane activator and calcium modulator ligand interactor Elsevier common variable immunodeficiency Elsevier natural antibodies |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j j l jj jjl e j ej s u su k l kl l g lg h b hb t s ts r b rb l h lh a c c ac acc r s rs j m jm r m rm r s g rs rsg |
hierarchy_parent_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
hierarchy_parent_id |
ELV000021164 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000021164 |
title |
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
ctrlnum |
(DE-627)ELV01471776X (ELSEVIER)S0091-6749(16)30892-2 |
title_full |
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
author_sort |
Jabara, Haifa H. |
journal |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
journalStr |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
1293 |
author_browse |
Jabara, Haifa H. |
container_volume |
139 |
physical |
11722 |
class |
610 610 DE-600 610 VZ 44.85 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Jabara, Haifa H. |
doi_str_mv |
10.1016/j.jaci.2016.07.028 |
dewey-full |
610 |
title_sort |
heterozygosity for transmembrane activator and calcium modulator ligand interactor a144e causes haploinsufficiency and pneumococcal susceptibility in mice |
title_auth |
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
abstract |
The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. |
abstractGer |
The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. |
abstract_unstemmed |
The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
4 |
title_short |
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice |
url |
https://doi.org/10.1016/j.jaci.2016.07.028 |
remote_bool |
true |
author2 |
Lee, John J. Janssen, Erin Ullas, Sumana Liadaki, Kyriaki Garibyan, Lilit Benson, Halli Sannikova, Tatyana Bram, Richard Hammarstrom, Lennart Cruz, Anthony C. Siegel, Richard Manis, John Malley, Richard Geha, Raif S. |
author2Str |
Lee, John J. Janssen, Erin Ullas, Sumana Liadaki, Kyriaki Garibyan, Lilit Benson, Halli Sannikova, Tatyana Bram, Richard Hammarstrom, Lennart Cruz, Anthony C. Siegel, Richard Manis, John Malley, Richard Geha, Raif S. |
ppnlink |
ELV000021164 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.jaci.2016.07.028 |
up_date |
2024-07-06T22:15:57.954Z |
_version_ |
1803869652732870656 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01471776X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623115317.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2016.07.028</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017001000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01471776X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(16)30892-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jabara, Haifa H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11722</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The B-cell receptor transmembrane activator and calcium modulator ligand interactor (TACI) is important for T-independent antibody responses. One in 200 blood donors are heterozygous for the TACI A181E mutation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pneumococcal susceptibility</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transmembrane activator and calcium modulator ligand interactor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">common variable immunodeficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">natural antibodies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, John J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Janssen, Erin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ullas, Sumana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liadaki, Kyriaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garibyan, Lilit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benson, Halli</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sannikova, Tatyana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bram, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hammarstrom, Lennart</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cruz, Anthony C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Siegel, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manis, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malley, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geha, Raif S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:139</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:1293-13014</subfield><subfield code="g">extent:11722</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2016.07.028</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">139</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">1293-13014</subfield><subfield code="g">11722</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4008503 |